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Most proteins made for export are synthesized on polysomes associated with 
the  membrane  of  the  rough  endoplasmic  reticulum  (RER). ~ The  nascent 
polypeptides enter the RER  and move through the membranes into smooth 
endoplasmic reticulum. Later they can be found in the Golgi apparatus from 
which they travel to the cell surface where they are released into the surround- 
ing medium (1). As might be expected, secretory proteins can often be detected 
on the cell surface (2). 
Most  secreted polypeptides are now known to be synthesized in precursor 
form with 10-30 extra amino acid residues on their amino terminal ends. The 
extra sequences are rich in hydrophobic amino acids (3-6). Blobel and Dobber- 
stein proposed that during the process of translation these signal sequences 
serve to anchor the polysomes in the membrane and direct the entry of the 
nascent chain into  the  RER  (7). Specific  proteolysis removes the  signal  se- 
quences,  probably  before  translation  of the  polypeptide  is  completed.  The 
polypeptide is then processed and assembled (1, 7-11). 
Immunoglobulin production in myeloma cells has been a model system used 
extensively in elucidating the pathway outlined above.  Mouse myeloma MOPC 
315 cells synthesize and secrete an immunoglobulin (Ig) of the IgA class. Both 
the light (L) and heavy (H) chains are made on membrane-bound polysomes 
(12). The heavy chain is modified by stepwise addition of sugar residues (13); 
during assembly it forms a dimer (H2) before combining with light chain (14). 
Just before secretion, J  chain joins the complex and polymeric IgA is formed 
(15,  16). Little is known about the regulation of this process.  By analyzing 
variant cell lines blocked at different stages in Ig maturation we hope to learn 
what controls secretion. In this paper we report studies on the synthesis and 
secretion of an altered a-heavy chain in the MOPC  315 variant line, 315LV-1 
which  has  lost  the  ability  to  make  any  k~  light  chain.  Cells  of 315LV-1 
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synthesize H chain but then degrade most of it rather than secrete it. Secretion 
of the a-chain is restored by fusion of 315LV-1  cells with cells of K-light chain 
producing myeloma variant of the MPC 11 cell line (4T001.01).  This phenome- 
non is reminiscent of L chain secretion in the MOPC 21 cell line (17). 
Materials and Methods 
Cell Lines and Culture Media.  Mouse myeloma MOPC 315 parent cell line 315LK produces 
both ~,2  light  chain and a-heavy chain. A tumor line,  NPI, was isolated  as a nonsecreting tumor 
by Lynch and co-workers by using techniques described previously (18);  an isolate  of it was 
adapted to tissue  culture and then a single cloned isolate  315LV-1 was obtained with standard 
procedures. Mouse myeloma MPC  11 lines,  kindly supplied by M. Scharff (Einstein University) 
are  4T001, a parent line  producing  K-light  and  T2b  heavy  chains  and a variant line  4T001.01, which 
only synthesizes and secretes K chain. The 4T001 cell  lines are 6-thioguanine  resistant and 
ouabain resistant.  A  hybrid line,  X-2, was constructed between 315LV-1 and 4T001.01 by using 
polyethylene glycol  as  a fusing agent (19). 
The cells were grown  and maintained  in Dulbecco's modified  Eagles' medium  (DMEM) 
supplemented with 20% fetal  calf  serum. For amino acid cell  labeling experiments,  medium 
lacking the appropriate amino acids  and containing dialyzed fetal  calf  serum was used. Radioac- 
tive  amino acids  threonine, leucine,  valine,  or  methionine were used as  indicated. 
Radioimmunoassay.  Radioimmunoassays  specific for  a- and T-heavy chains  and  K- and ~- 
light chains were performed as described elsewhere.1 
Samples of either cell cytoplasmic lysates (i.e., post nuclear supornates of Nonidet P40 lysed 
cells), cell secretions (i.e., medium) or unlysod cells (washed twice in DMEM supplemented with 
fetal calf serum) were used as indicated. 
Preparation of Labeled Cell Cytoplasmic Ig Proteins.  After the appropriate  incubation and 
labeling  treatments, cell  suspensions were chilled  and centrifuged for 5 rain at 1,500  rpm in an 
International centrifuge (International  Equipment Co., Boston, Mass.). The cells  were washed 
with  50  mM  Tris-HCl (pH 7.6)  + 50  mM  NaCl (TN)  buffer  and  resuspended and  lysed in  TN buffer 
+ 1% Nonidet P40 (Gallard-Schlesinger Chemicals Mfg. Corp., Carle Place, N. Y.).  Debris and 
nuclei were removed from the cytoplasmic proteins by centrifugation at 1,000  g for 10 min. The 
Ig  proteins  were purified  by either  of  two methods. Staphylococcus A precipitation  was performed 
as described,  ~ but by using two times the amount of fixed  bacteria for each sample. Indirect 
precipitation  from the soluble proteins was carried out as follows:  the supernate of  a 100,000  g 
(30 rain)  centrifugation was incubated in phosphate-buffered saline (PBS) with rabbit anti-315 
protein  serum for  2 h at  room temperature.  Goat anti-rabbit  Ig  serum was added and the incuba- 
tion continued for an equal time followed by an overnight incubation at 4°C. Precipitates  were 
centrifuged  through a 0.3-mi  cushion  of  1  M  sucrose  in  PBS containing detergents (PBS, 1%  Triton 
X-100, 1%deoxycholate) for 10 rain  at 9,000  rpm in a Sorvall  centrifuge (Ivan Sorvall,  Inc.,  New- 
town, Conn.). The pellets  were washed several  times in PBS-detergents, then in TN buffer,  and 
finally resuspended in 50 mM  Tris-HCl (pH 7.6)  containing  2% sodium dodecyl sulfate and 
dissolved  by heating for 1 min in boiling  water. 
RNA  Translation in  a Wheat Germ Cell-Free  System.  To isolate  polysomes, cells  were chilled 
quickly,  washed with a 0.85% saline  solution,  and swollen hypotonically in 10 mM  Tris-HCl (pH 
7.6),  10  mM  KCI, I  mM  MgCI2. For  a total  polysome preparation,  cells  were lysecl  with 1% Nonidet 
P40, nuclei  removed by  centrifugation,  and  polysomes purified  by  precipitation  with 30  mM  MgCl2 
(20).  When membrane bound and free  polysomes were to  be separated, swollen suspensions were 
adjusted to 10 mM  Tris-HCl (pH 7.6),  100 mM  KCI, 1 mM  MgCI2, 0.88  M  sucrose,  and the cells 
lysed  by Dounce homogenization. The polysome fractionation  and total  RNA extraction  proceeded 
as described previously (21).  A  wheat germ cell-free  system was prepared and 25-/~I  reactions 
incubated with 0.25  OD2eo total  RNA  and 25 ~Ci [3sS]methionine as described by Roberts and 
Paterson (22).  After 3 h at room temperature, reactions  were centrifuged at 100,000  g for  30 rain 
and the light-  and heavy-chain polypeptides purified  by a direct  immune precipitation.  In this 
case it  was important to  allow  only a short incubation period (no more than 2 h at  room tempera- 
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ture) to keep the background of nonspecific protein precipitation low. The precipitates were 
washed and dissolved  as described above. 
Polyacrylamide Gel Electrophoresis.  Samples were adjusted to 50 mM Tris-HC1 (pH 7.6), 2% 
sodium dodecyl  sulfate, 75 mM fl-mercaptoethanol,  10% glycerol,  then heated in boiling water for 
1 min, and subjected to electrophoresis  on gradient polyacrylamide-sodium  dodecyl  sulfate slab 
gels (with a 3% stacking region) as described previously (23). After staining with Coomassie Blue 
and destaining, gels were either prepared for fluorography (24, 25) or dried down directly. 
Reagents.  Rabbit  anti-mouse myeloma a-460 protein (IgA, K) antiserum was obtained from 
Gateway Immunosera Co., St.  Louis, Mo.  Preparation of immunoglobulin proteins and other 
antisera were as described.  2 
Results 
The 315LV-1 tumor selected as a  nonsecreting myeloma, was found to have 
low intracellular levels of immunoglobulin heavy chain  (H.  Eisen,  personal 
communication). Its growth was adapted to tissue culture and a  single clonal 
derivative was isolated. The level of H  and L chain present in the cytoplasm 
was  tested  by  radioimmunoassay.  Cells  of the  315LV-1  line  were  found  to 
contain approximately 1-3% of  the level of intracellular H chain found in 315LK 
cells (Table I). No k2 light chain could be detected in 315LV-1 (Table I). When a 
hybrid  line  (X-2)  was  made  by  fusing  315LV-1  cells  with  a  light  chain  (K) 
producing MPC 11 clone (4T001.01), the intracellular a-chain level increased to 
about the level found in the wild type 315LK line. No induction of h2 light chain 
or increase in the very low steady-state level of T2b was  observed. Thus the 
hybrid cell X-2 does not show complementation of either of these nonexpressed 
chains  (footnote II,  Table I).  Synthesis of K-light chain is continued as in the 
4T001.01 parent.  Neither of the defects resulting in failure to produce a  given 
chain is a dominant phenotype since the hybrid cell continued to express chains 
of both of its parental lines (315LV-1  and 4T001.01) (Table I). 
Loss of Secretion of the a-Heavy Chain in 315LV-1.  To compare quantita- 
tively the level of  secretion of H chain in 315LK and 315LV-1 cells, exponentially 
growing cultures were diluted to the same density and grown for 72 h.  After 
counting the cells, they were removed by centrifugation and the level of H chain 
in  the  culture  medium  was  measured  by  radioimmunoassay.  The  average 
number of cells was calculated by integration of the initial and final cell counts. 
The 315LK cells were found to secrete an average of 2.6  x  10  -7  ~g/cell per h 
(Table II).  For the 315LV-1,  the maximum amount of medium that could be 
added gave a response that was barely above background. We estimate a value 
of 4  x  10  TM  ~g/cell  per  h  for  this  line  (Table  II).  From  the  intracellular 
concentration of a-chain in 315LV-1 one would expect a level of secretion equal 
to  1%  of the  level  seen  in  the  parent  315LK line  if secretion were not  also 
defective in this mutant. 
Recovery of Heavy-Chain Secretion in the Hybrid X-2.  The X-2 hybrid cell 
line not only has high intracellular levels of H  chains but also secreted the H 
chain it synthesized. Thus in an  Ouchterlony double-diffusion plate test,  the 
culture  fluids  of 315LK  and  X-2  cells  both  gave  positive  responses  when 
challenged with rabbit antiserum directed against the myeloma a-chain protein 
of MOPC 460 whereas 315LV-1 culture fluids gave no response (data not shown). 
When tested by radioimmunoassay, the medium from X-2 cells was found to 
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TABLE  I 
Steady-State  Intracellular Immunoglobulin Chain Levels 
Cell line 
Cell protein  a 
a  k25  72b  K* 
% 
315LK  1.4  1.8  *§  * 
315LV-1  0.01  *  *  * 
4T001  *  *  3.1  6.3 
4T001.01  *  *  0.02~1  1.0 
X-2  1.1  *  0.0~1  3.1 
a  Error in determination +_- 30% of listed value. 
* If parental H2~ can be formed, free light chain is underestimated. 
This is also true for the X-2 cell line. Otherwise, total light chain can 
be determined. 
§ Star (*) signifies less than 10 -4 of positive control. 
II  The level of 72b  antigen detected is significantly above background. 
Preliminary experiments suggest that  it represents a  low level of 
complete 72b H chain being synthesized in 4T001.01 and X-2. 
TABLE  II 
Secreted and Cell Surface a-Heavy Chain 
Molecules*/cell sur- 
Cell line  ~zg a-Chain*  face 
cell/h 
315LK  2.6  ×  10 -7  5.0  ×  105 
315LV-1  <4  ×  10 -11  <2  x  103 
X-2  2.2  ×  10  -7  3.6  x  105 
* Error in determination --- 50% of listed value. 
$ Assay  actually  measures  a-chain  molecule  equivalents.  Error  in 
determination -+ 15% of listed value. 
Synthesis Rate of the Ig Proteins.  To  measure the  rates  of synthesis of 
immunoglobulin chains, cells were labeled with [=S]methionine for 20 min and 
the  L  and  H  chains  were purified by  immune precipitation  of cytoplasmic 
proteins as described in Materials and Methods. The immunoglobulin chains in 
the precipitates were reduced with mercaptoethanol and subjected to electropho- 
resis in polyacrylamide-sodium dodecyl sulfate gels. Labeled bands were visu- 
alized by fluorography. As shown in Fig.  1,  the 315LV-1 cells synthesized a- 
heavy chain at about the same rate as did 315LK cells. Thus the low intra- 
cellular level of H chain is not due to a failure of  the cell to synthesize H chain in 
315LV-1. The possibility that intracellular degradation is responsible for lack of 
secretion and the low steady-state level was explored next. 
Turnover  of Immunoglobulin  Protein.  Since  the  heavy  chain  does  not 
FIG.  1.  Cellular rates of synthesis of immunoglobulin chains. Cell cultures were incu- 
bated with 10  ~Ci/ml of [35S]methionine for 30 min in medium lacking cold methionine. 
Cells were harvested, washed, lysed, and nuclei removed by centrifugation as described in 
Materials and Methods. The Ig proteins, purified by immune precipitation, were electro- 
phoresed on 7.5-20% gradient polyacrylamide-sodium  dodecyl sulfate gels and fluorograms 
prepared as described. FIG.  1 
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Fro.  2.  Stability of cellular immunoglobulin proteins.  Cultures of 315LK,  315LV-1, and 
X-2 cells were incubated with 10  ~Ci/ml [3~S]methionine in medium lacking cold methio- 
nine.  After 20  min,  a  sample was removed, and  excess unlabeled methionine added to 
prevent further  incorporation of label  (0  min time).  After incubation  for the  indicated 
length of time, samples were removed, cells were lysed, and immune precipitates prepared. 
Fluorograms  of the  proteins  electrophoresed  on  5-15% polyacrylamide-sodium dodecyl 
sulfate gradient gels were prepared as described above. Lane l:315LK; lane 2:315LV-1; lane 
3:X-2. 
appear to be secreted or accumulate within the cell, one can postulate that H 
chain  is  degraded  intracellularly in  315LV-1.  To  test  this  hypothesis,  cell 
suspensions  of 315LK, 315LV-1, and  X-2  were  incubated  with  10  ~Ci/ml 
[~S]methionine; after 20 min a 130-fold excess of cold methionine was added to 
prevent further incorporation of label. Samples removed after various times of 
incubation were lysed as described above and the H and L chains purified by 
immune precipitation with Staphylococcus A and subjected to gel electrophore- 
sis (Fig. 2). The incorporation of [~S]methionine in 315LV-1 cells was somewhat 
lower than in 315LK or X-2. The gels from this and a similar experiment, where 
the amounts of incorporation were equal, were scanned and the amount of label 
in  H  chain  determined.  The  label  in  the  a-chain  of 315LK  and  X-2  was 
essentially stable over a  60-min period.  In contrast,  the label in 315LV-1 H 
chain began to decline immediately and by 60  min had nearly disappeared. 
Thus it appears that turnover of a-chain in 315LV-1 cells is much more rapid 
than in either 315LK or X-2 cells. Presumably this turnover is due to intracel- 
lular degradation. We do not find any evidence either for precipitated H chain 
associated with the nuclear pellet or for extracellular or surface antigens cross- 
reacting with H chain. (Data not shown.) 
Nature of the Heavy Chain in 315LV-1  and X-2.  It can be seen in Figs.  1 
and  2  that  the  H  chain  synthesized in  315LV-1 migrates slightly faster in 
acrylamide gel electrophoresis than does the H  chain from 315LK cells. The 
hybrid X-2 synthesized an H chain similar in migration to 315LV-1 a-chain. To 
determine whether the  faster migration was  due to  a  size  difference or to 
aberrant a-chain processing in 315LV-1 and X-2 cells, total pelysomal RNA was 
extracted from the three lines and used to direct translation in vitro in a wheat 
germ cell-free system.  Ig  proteins  among the  products  of translation  were 
collected by immune precipitation and analyzed on polyacrylamide gradient 
gels as described above (Fig. 3). The amount ofprecipitable H chain synthesized 
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FIG.  3.  Electrophoretic  analyses  of translation  products  obtained  with  either  total  or 
fractionated  RNA  preparations.  RNA,  extracted  either  from  total  polysomes  or  from 
fractionated membrane-bound  and free polysomes, was used to direct a  wheat germ cell- 
free system. After incubation for 3 h at 23°C, reactions were centrifuged at 100,000 g  for 30 
min. The supernate,  i.e. released proteins, were immune precipitated and electrophoresed 
as described above. Products were obtained either with: total, total RNA; A, free polysomal 
RNA; B, membrane-bound polysomal RNA. 
lines.  The RNA from both 315LV-1  and X-2 cells directed synthesis of heavy 
chain with greater electrophoretic mobility than did RNA from 315LK cells. It 
is unlikely that any processing such as clipping of a precursor or carbohydrate 
addition occurred in vitro in the wheat germ lysate. From a similar gel in which 
marker proteins were included one can estimate that the a-chain synthesized in 
315LV-1 and X-2 cells is approximately 3,000 daltons smaller than the one made 
in 315LK  cells.  Consequently we refer to  it  as  H'  chain.  The nature of the 
alteration is presently unknown. Regardless of the alteration in the H chain, it 
is unlikely that it affects the phenotype we have observed in 315LV-1  (i.e., lack 
of secretion and high turnover rate) since the same H' chain is made in both 308  IMMUNOGLOBULIN  SECRETION 
315LV-1 and X-2. The hybrid cell line does not show the phenotype of 315LV-1. 
Site  of Ig  Synthesis  and Processing.  Since  the  H  chain  synthesized  in 
315LV-1 cells was not secreted,  it was of interest to know whether its mRNA 
was bound to membranes. Therefore, polysomes were separated into membrane- 
bound and free fractions and the extracted RNA used to program a wheat germ 
cell-free system. The free and membrane-bound populations were equally active 
in the synthesis of proteins in vitro. For all three cell lines, however, only the 
membrane-associated  polysomal RNA directed the  synthesis of the  immuno- 
globulin chains (Fig. 3). Thus the mRNA active in the synthesis of H' chain in 
315LV-1 cells is associated with membranes. 
To test whether any H' chain in fact reaches the cell surface of 315LV-1, cells 
were grown for two generations, collected and washed twice with fresh medium 
and  samples  tested  by  radioimmunoassay.  The  results  shown  in  Table  II 
indicate that the relative amount of a-chain on the surface of 315LV-1 cells is no 
more than  that  found intracellularly  (the  analysis is not sensitive enough to 
detect much less than 1% of the parental amount). In addition, 315LK, 315LV-1, 
and  4T001  cells  were  tested  for  cell  surface  a-H  chain  on  the  fluorescence 
activated cell sorter (courtesy S. Schlossman). The 315LV-1 cells were indistin- 
guishable  from  the  negative  control  4T001,  whereas  315LK  showed  bright 
fluorescence (G. R. Siebert, unpublished observations). 
Discussion 
Initial selection of the NP1 tumor was based on loss of Ig secretion. The tissue 
culture line, derived from the tumor (315LV-1) contains low levels of an H  (H') 
chain of altered electrophoretic mobility and no detectable amount of L chain. It 
secretes essentially none of the H' protein and very little can be detected on the 
cell  surface.  Surprisingly  we find that  the  rate  of the  H'  chain  synthesis  in 
315LV-1  is  similar  to  that  of the  H  chain  in  315LK  control  cells.  Lack  of 
appearance of extracellular  H' chain seems to be at least partially due to rapid 
turnover in 315LV-1 cells. The lesion(s) responsible for altered H chain process- 
ing,  resulting in nonsecretion and rapid degradation,  can be complemented by 
cell fusion with an MPC 11 ~-producing variant clone. The hybrid cell synthe- 
sizes the same H' chain in the same amount as the 315LV-1 parent but it secretes 
it  in  a  complete  Ig  molecule  with  the  K-L  chain. 2 On  the  other  hand  the 
alteration(s) in the 315LV-1 H chain was not corrected by fusion with 4T001.01. 
This lesion, however, is not likely to be responsible for the observed phenotype 
of 315LV-1 (i.e., lack of secretion and turnover) since it is not exhibited by X-2 
which also synthesizes the altered H chain. 
It  is noteworthy that  in these experiments,  as well as in  those previously 
reported  (17,  26,  27),  cell  fusion has  not resulted  in  complementation  of the 
mutation  which  originally  led  to  loss of synthesis  of an  H  or  L  chain.  X-2 
produces neither the 315 L chain nor the MPC 11 H chain in wild type amounts. 
Negative complementation  is also not observed.  X-2 continues to produce the 
a-H chain and K-L chain synthesized in the parents. The only complementation 
we have observed is the  stabilization  and secretion of the altered H  chain in 
X-2. 
The phenomenon of recovery of secretion may be similar to that reported by 
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which synthesizes only light chains but does not secrete them. The variant line 
was fused with the P1 myeloma line, which synthesized and secreted excess free 
light chains in addition to H2L~. In the hybrid, the P3 r-chain was secreted, but 
only in a  covalent structure with the P1 heavy chain and not as free L chain. 
Thus the lack of secretion of L chain in the parent was recovered in the hybrid. 
Furthermore  these authors  isolated variants of the hybrid which had lost P1 
heavy  chain  production  and  all  of the  resultant  segregants  had  also  lost 
secretion  of  P3  light  chain  even  though  they  still  contained  the  protein 
intracellularly.  (They continued to secrete the free P1 light chain.) Thus the P3 
K-chain seems to require a heavy chain for secretion. The rates of synthesis and 
degradation of the nonsecreted L chain were not examined in that study. 
Morrison and Scharff (28) have isolated heavy-chain producing variant lines 
of P3.  In  those  lines,  although  the  H  chain  is not secreted,  its  intracellular 
concentration is like that of the parent.  The authors conclude that a decreased 
rate of synthesis rather than turnover,  is responsible for the level of H  chain 
found. 
A  major  difference  between the  P3  case  and  that  of 315LV-1  is  the  rapid 
degradation  of the nonsecreted  a-H' chain in 315LV-1. An explanation of this 
phenomenon may be that in the absence of light chain, a free a-chain may not 
assume the appropriate secondary structure and may therefore be susceptible to 
proteolysis.  Such  a  model  has  been  proposed  by Schubert  and  Cohn  (29)  to 
explain  their  observation  with  a  P1  myeloma  variant  line.  In  this  line  an 
altered  H  chain  was synthesized which could not combine with the  L  chain. 
They found, as in the P3 variants discussed above, that the free H chain did not 
accumulate nor was it secreted.  In this case,  it was degraded intracellularly, 
presumably at a rate equivalent to its synthetic rate. The increased degradation 
of the H' chain in 315LV-1 could be due solely to its unassociated state, although 
alternative explanations are possible (see below). 
Experiments of Hickman et al.  (30) suggest that glycosylation is required for 
a-chain  secretion in MOPC 315.  When they added the glycosylation inhibitor 
tunicamycin  to cell cultures,  secretion of H  chain  was blocked; whereas  in a 
MOPC  315  L-chain  producing  variant  line,  the  unglycosylated ~2  chain  was 
secreted  normally.  Although  tunicamycin  may  have  had  pleiotropie  effects, 
these experiments seem to indicate that glycosylation is required for secretion 
in MOPC 315. Possibly in 315LV-1 the H' chain cannot be glycosylated correctly. 
One would propose that the MPC  11  r-chain  producing cell is able to comple- 
ment the lesion in the glycosylation system.  We are currently examining the 
pattern of carbohydrate addition to H' in 315LV-1 and in X-2. It should be noted 
that whereas normal MOPC 315 a-chain was not degraded when secretion was 
inhibited with tunicamycin,  it is possible that unglycosylated H' chain might 
be  susceptible to  proteolysis.  To  test  all  these  possibilities  we  are  presently 
trying  to  isolate  revertants  of 315LV-1  which  have  recovered  the  ability  to 
secrete the  H'  chain.  In addition  we are  attempting  to isolate more H  chain 
producing variants of 315LK to examine a-chain secretion in these lines. 
The  MOPC  315  H  chain  has  recently  been  shown  to  be  synthesized  in  a 
precursor form (6), as has been shown for L chain and other secretory proteins 
(3-6).  It would be interesting to determine whether this is true for the altered 
315LV-1 H' chain as well. 310  IMMUNOGLOBULIN  SECRETION 
Mosmann and Baumal (31) have looked at MOPC 315 variant cells which do 
not synthesize detectable amounts  of H  chain,  but do produce and  secrete  L 
chains. These variants synthesize but no longer secrete J chain, which normally 
is covalently attached to the Fc portion of the H chain (16). Since the addition of 
J  chain is a very late step in maturation of 315 protein, the J  chain presumably 
must  enter  the  membrane  itself.  However without  the  H  chain  it  remains 
intracellular.  This suggests yet another form of regulation of secretion. We hope 
that continued study of nonsecreting variants of these myeloma cell lines will 
further our understanding of these different levels of regulation involved in the 
control of secretion of immunoglobulin molecules. 
The results presented in this paper and in Siebert et al. 2 suggest a mechanism 
that may be involved in the selection of functional H,L pairs.  A developing cell 
may successively produce different H and L chains. If those heavy chains unable 
to combine with  a  light  chain  are  degraded  intracellularly,  they will fail  to 
reach  the  cell  surface.  Thus  the  synthesis  of functional  H,L  pairs  could  be 
stabilized by a feedback mechanism which recognizes complete immunoglobulin 
on the cell surface. 
Summary 
Cells of the 315LV-1  (derived from NP1) variant  line of MOPC 315 contain 
approximately 1% the normal intracellular  level of the heavy (a) chain of IgA 
and no detectable light (~,2) chain. The synthesis rate of a-chain in the variant, 
however,  is similar  to that  in cells of the  parent  line.  Moreover the relative 
amount of translatable  a-chain mRNA that can be extracted from 315LV-1 cells 
is about the same as for parental cells. No light-chain synthesis can be detected 
either in vivo or in vitro in a  wheat germ cell-free system. The 315LV-1 heavy 
chain synthesized in vivo or in vitro has slightly greater electrophoretic mobility 
than normal H chain and turns over rapidly intracellularly.  The variant fails to 
secrete any of its heavy chain, despite the fact that its H chain mRNA is bound 
to membranes,  as one would expect for a  secretory protein message. Fusion of 
315LV-1  cells  with  cells  of  a  K-producing  MPC  11  variant  line  leads  to 
stabilization of the intracellular H chain and also to full recovery of secretion of 
the H chain as an H2L2 molecule. 
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